Search Results - Peter B. Gilbert

Refine Results
  1. 1

    Predicting neutralization susceptibility to combination HIV-1 monoclonal broadly neutralizing antibody regimens. by Brian D Williamson, Liana Wu, Yunda Huang, Aaron Hudson, Peter B Gilbert

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  2. 2

    FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells. by Xinxia Peng, Shuying S Li, Peter B Gilbert, Daniel E Geraghty, Michael G Katze

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  3. 3

    Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention. by Bryan T Mayer, Allan C deCamp, Yunda Huang, Joshua T Schiffer, Raphael Gottardo, Peter B Gilbert, Daniel B Reeves

    Published in PLoS Computational Biology (2022-04-01)
    Get full text
    Article


  4. 4

    Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based model... by Yunda Huang, Ann Duerr, Nicole Frahm, Lily Zhang, Zoe Moodie, Steve De Rosa, M Juliana McElrath, Peter B Gilbert

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  5. 5

    Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research by Brian D. Williamson, Craig A. Magaret, Shelly Karuna, Lindsay N. Carpp, Huub C. Gelderblom, Yunda Huang, David Benkeser, Peter B. Gilbert

    Published in iScience (2023-09-01)
    Get full text
    Article


  6. 6

    Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials by Yunda Huang, Shelly Karuna, Lindsay N. Carpp, Daniel Reeves, Amarendra Pegu, Kelly Seaton, Kenneth Mayer, Joshua Schiffer, John Mascola, Peter B. Gilbert

    Published in Human Vaccines & Immunotherapeutics (2018-09-01)
    Get full text
    Article


  7. 7

    Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection by David S. Khoury, Timothy E. Schlub, Deborah Cromer, Megan Steain, Youyi Fong, Peter B. Gilbert, Kanta Subbarao, James A. Triccas, Stephen J. Kent, Miles P. Davenport

    Published in Emerging Infectious Diseases (2023-02-01)
    Get full text
    Article


  8. 8

    Tracking SARS-CoV-2 Spike Protein Mutations in the United States (January 2020—March 2021) Using a Statistical Learning Strategy by Lue Ping Zhao, Terry P. Lybrand, Peter B. Gilbert, Thomas R. Hawn, Joshua T. Schiffer, Leonidas Stamatatos, Thomas H. Payne, Lindsay N. Carpp, Daniel E. Geraghty, Keith R. Jerome

    Published in Viruses (2021-12-01)
    Get full text
    Article


  9. 9

    Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine... by Andrew Fiore-Gartland, Bryce A Manso, David P Friedrich, Erin E Gabriel, Greg Finak, Zoe Moodie, Tomer Hertz, Stephen C De Rosa, Nicole Frahm, Peter B Gilbert, M Juliana McElrath

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  10. 10

    Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial by Nima S. Hejazi, Xiaoying Shen, Lindsay N. Carpp, David Benkeser, Dean Follmann, Holly E. Janes, Lindsey R. Baden, Hana M. El Sahly, Weiping Deng, Honghong Zhou, Brett Leav, David C. Montefiori, Peter B. Gilbert

    Get full text
    Article


  11. 11

    GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies. by Lin Lin, Rachel L Spreng, Kelly E Seaton, S Moses Dennison, Lindsay C Dahora, Daniel J Schuster, Sheetal Sawant, Peter B Gilbert, Youyi Fong, Neville Kisalu, Andrew J Pollard, Georgia D Tomaras, Jia Li

    Published in PLoS Computational Biology (2024-11-01)
    Get full text
    Article


  12. 12

    SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and as... by Tim R. Mosmann, Jonathan A. Rebhahn, Stephen C. De Rosa, Michael C. Keefer, M. Juliana McElrath, Nadine G. Rouphael, Giuseppe Pantaleo, Giuseppe Pantaleo, Peter B. Gilbert, Lawrence Corey, James J. Kobie, Juilee Thakar

    Published in Frontiers in Immunology (2024-06-01)
    Get full text
    Article


  13. 13

    Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America. by Lindsay N Carpp, Youyi Fong, Matthew Bonaparte, Zoe Moodie, Michal Juraska, Ying Huang, Brenda Price, Yingying Zhuang, Jason Shao, Lingyi Zheng, Laurent Chambonneau, Robert Small, Saranya Sridhar, Carlos A DiazGranados, Peter B Gilbert

    Published in PLoS ONE (2020-01-01)
    Get full text
    Article


  14. 14

    Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission by David A. Swan, Ashish Goyal, Chloe Bracis, Mia Moore, Elizabeth Krantz, Elizabeth Brown, Fabian Cardozo-Ojeda, Daniel B. Reeves, Fei Gao, Peter B. Gilbert, Lawrence Corey, Myron S. Cohen, Holly Janes, Dobromir Dimitrov, Joshua T. Schiffer

    Published in Viruses (2021-09-01)
    Get full text
    Article


  15. 15

    Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials. by Daniel B Reeves, Yunda Huang, Elizabeth R Duke, Bryan T Mayer, E Fabian Cardozo-Ojeda, Florencia A Boshier, David A Swan, Morgane Rolland, Merlin L Robb, John R Mascola, Myron S Cohen, Lawrence Corey, Peter B Gilbert, Joshua T Schiffer

    Published in PLoS Computational Biology (2020-02-01)
    Get full text
    Article


  16. 16

    Realising the potential of correlates of protection for vaccine development, licensure and use: short summary by Deborah F. King, Helen Groves, Charlie Weller, Ian Jones, Jakob P. Cramer, Peter B. Gilbert, David Goldblatt, Marion F. Gruber, Beate Kampmann, Diadié Maïga, Marcela F. Pasetti, Stanley A. Plotkin, Alexander Precioso, Liya Wassie, Frederick Wittke, David C. Kaslow

    Published in npj Vaccines (2024-04-01)
    Get full text
    Article


  17. 17

    A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19 by Rhiannon Edge, Sam Matthews, Bahar Ahani, Anastasia A. Aksyuk, Lindsay Clegg, John L. Perez, Mark T. Esser, Lee-Jah Chang, Ian Hirsch, Tonya Villafana, John Pura, Oleg Stepanov, Katie Streicher, Tom White, Taylor S. Cohen, Dean Follmann, Peter B. Gilbert, Seth Seegobin

    Published in Nature Communications (2025-10-01)
    Get full text
    Article


  18. 18

    Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses by Ying Huang, Shomoita Alam, Erica Andersen-Nissen, Lindsay N. Carpp, One B. Dintwe, Britta S. Flach, Nicole Grunenberg, Fatima Laher, Stephen C. De Rosa, Guido Ferrari, Craig Innes, Linda-Gail Bekker, James G. Kublin, M. Juliana McElrath, Georgia D. Tomaras, Glenda E. Gray, Peter B. Gilbert

    Published in Viruses (2024-08-01)
    Get full text
    Article


  19. 19

    Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk. by Erica Andersen-Nissen, Andrew Fiore-Gartland, Lamar Ballweber Fleming, Lindsay N Carpp, Anneta F Naidoo, Michael S Harper, Valentin Voillet, Nicole Grunenberg, Fatima Laher, Craig Innes, Linda-Gail Bekker, James G Kublin, Ying Huang, Guido Ferrari, Georgia D Tomaras, Glenda Gray, Peter B Gilbert, M Juliana McElrath

    Published in PLoS Pathogens (2021-03-01)
    Get full text
    Article


  20. 20

    Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants by Yunda Huang, Lily Zhang, Amanda Eaton, Nonhlanhla N. Mkhize, Lindsay N. Carpp, Erika Rudnicki, Allan DeCamp, Michal Juraska, April Randhawa, Adrian McDermott, Julie Ledgerwood, Philip Andrew, Shelly Karuna, Srilatha Edupuganti, Nyaradzo Mgodi, Myron Cohen, Lawrence Corey, John Mascola, Peter B. Gilbert, Lynn Morris, David C. Montefiori

    Published in Human Vaccines & Immunotherapeutics (2022-01-01)
    Get full text
    Article


Search Tools: